Injected muscle | 1996 | 1997 | 1998 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
July | October | January | May | September | January | |||||
Trapezium | 50 UI BOTOX® (each trapezium) | 30 UI BOTOX® (right trapezium) | 30 UI BOTOX®(each trapezium) | 20 UI BOTOX® (each trapezium) | 20 UI BOTOX® (each trapezium) | 10 UI BOTOX®(each trapezium) | ||||
Esternocleidomastoid (ECM) | 30 UI BOTOX® (each ECM) | 30 UI BOTOX® (Each ECM) | ||||||||
Paracervical musculature | 20 UI BOTOX® (each side) | 15 UI BOTOX® (each side) |
The patient received 50 IU BOTOX® (Allergan) in three different locations of each trapezium on 17 July 1996; on 24 October 1996, 30 IU BOTOX were administered in each esternocleidomastoid and 30 IU in right trapezium; on 22 January 1997 30 IU BOTOX were given in each esternocleidomastoid and trapezium; on 21 May 1997 20 IU BOTOX were given in each trapezium; on 25 September 1997 40 IU BOTOX were given in each trapezium and bilateral paracervical musculature (total 80 IU); on 15 January 1998 10 IU BOTOX were given in each trapezium and 30 IU in paracervical musculature bilaterally.